​

Corvus Pharmaceuticals (CRVS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Corvus Pharmaceuticals Revenue Highlights

00

Corvus Pharmaceuticals Revenue by Period

Corvus Pharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31--

Corvus Pharmaceuticals generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Corvus Pharmaceuticals Revenue by Quarter

DateRevenueChange
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$88.00K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$246.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31--

Corvus Pharmaceuticals generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Corvus Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
AKBAAkebia Therapeutics$160.18M$58.77M
PRTAProthena$135.16M$2.42M
GOSSGossamer Bio$114.70M$13.29M
RGNXREGENXBIO$83.33M$29.73M
VSTMVerastem$10.00M$11.24M
ABSIAbsci$4.53M$378.00K
CRVSCorvus Pharmaceuticals--
CMPXCompass Therapeutics--
VTYXVentyx Biosciences--
KALVKalVista Pharmaceuticals-$13.69M
OLMAOlema Pharmaceuticals--

CRVS Revenue FAQ

What is Corvus Pharmaceuticals’s yearly revenue?

Corvus Pharmaceuticals's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. CRVS's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Corvus Pharmaceuticals’s quarterly revenue?

Corvus Pharmaceuticals's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). CRVS's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Corvus Pharmaceuticals’s revenue growth rate?

Corvus Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.